[PDF][PDF] SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors

…, A Khmelevskaya, DV Dianov, M Malasheva… - Immunity, 2020 - cell.com
Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting
the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-…

SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors (preprint)

…, A Khmelevskaya, DV Dianov, M Malasheva… - 2020 - pesquisa.bvsalud.org
Understanding the hallmarks of the adaptive immune response to SARS-CoV-2 is critical for
fighting the COVID-19 pandemic. We assessed the antibody and T-cell reactivity in COVID-…

Zornikova, Dmitry Kiryukhin, Aleksei Titov, Iuliia O. Peshkova, Alexandra Khmelevskaya, Dmitry V. Dianov, Maria Malasheva, Anton Shmelev, Yana Serdyuk, Dmitry V …

…, A Khmelevskaya, DV Dianov, M Malasheva… - Immunity, 2020 - elibrary.ru
Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting
the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-…

[PDF][PDF] Tracking SARS-CoV-2 T cells with epitope-T-cell receptor recognition models

P Meysman, A Postovskaya, N De Neuter, B Ogunjimi… - BioRxiv, 2020 - scholar.archive.org
The emergence of a novel coronavirus in 2019, termed SARS-CoV-2, has led to the most
prominent global pandemic in recent history. Infection by SARS-CoV-2 manifests as COVID-19, …

Memory B cell and humoral responses elicited by Sputnik V in naïve and COVID-19-recovered vaccine recipients

MG Byazrova, SV Kulemzin, EA Astakhova… - MedRxiv, 2021 - medrxiv.org
The development of effective vaccines against SARS-CoV-2 remains a global health priority.
Despite extensive use, the effects of Sputnik V on B cell immunity need to be explored in …

[HTML][HTML] IgG antibodies develop to spike but not to the nucleocapsid viral protein in many asymptomatic and light COVID-19 cases

M Tutukina, A Kaznadzey, M Kireeva, I Mazo - Viruses, 2021 - mdpi.com
Since SARS-CoV-2 appeared in late 2019, many studies on the immune response to COVID-19
have been conducted, but the asymptomatic or light symptom cases were somewhat …

[PDF][PDF] SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

PA Mudd, AA Minervina, MV Pogorelyy, JS Turner… - Cell, 2022 - cell.com
… draining axillary lymph node through at least day 60 following primary vaccination and
persisted at high frequency in three of the five study subjects through day 200 following primary

[HTML][HTML] Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector

I Isakova-Sivak, E Stepanova, V Matyushenko… - Vaccines, 2022 - mdpi.com
The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all
countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve, …

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses

B Agerer, M Koblischke, V Gudipati… - Science …, 2021 - science.org
CD8 + T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus
control. Here, we identified nonsynonymous mutations in MHC-I-restricted CD8 + T cell …

[PDF][PDF] Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

S Weingarten-Gabbay, S Klaeger, S Sarkizova… - Cell, 2021 - cell.com
T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the
repertoire of naturally processed and presented viral epitopes on class I human leukocyte …